Can Low B12 Levels Cause Raised SGOT/SGPT Levels?
No, low vitamin B12 levels do not directly cause elevated AST (SGOT) or ALT (SGPT) levels. The available guidelines and research evidence do not establish vitamin B12 deficiency as a recognized cause of aminotransferase elevation.
Understanding the Relationship
The ACR Appropriateness Criteria 1 comprehensively outline the causes of elevated aminotransferases and do not list vitamin B12 deficiency among them. When AST and ALT are elevated, the guidelines identify specific hepatocellular injury patterns caused by:
- Fatty liver disease (NAFLD/NASH) - most common cause
- Viral hepatitis (B, C)
- Alcohol-induced liver disease
- Drug-induced liver injury
- Autoimmune hepatitis
- Hemochromatosis, Wilson disease, alpha-1 antitrypsin deficiency
- Ischemic hepatitis or Budd-Chiari syndrome
Notably absent from this comprehensive list is vitamin B12 deficiency.
What B12 Deficiency Actually Causes
The AACE/ACE guidelines 2 clearly describe the manifestations of vitamin B12 deficiency:
- Hematologic: Macrocytic anemia
- Neurologic: Peripheral neuropathy, cognitive impairment
- Psychiatric: Depression, confusion
- Other: Glossitis, elevated methylmalonic acid
Liver enzyme elevation is not mentioned as a consequence of B12 deficiency.
The Reverse Association: Liver Disease Affecting B12
The relationship actually works in the opposite direction - liver disease can affect vitamin B12 levels, not the other way around:
- Research shows that patients with NAFLD have lower vitamin B12 levels compared to controls, particularly in grade 2-3 hepatosteatosis 3
- In anorexia nervosa with liver involvement, elevated vitamin B12 concentrations correlate positively with elevated liver enzymes (AST, ALT, GGT), suggesting the liver releases stored B12 during hepatocellular injury 4
Clinical Pitfalls to Avoid
Do not attribute elevated transaminases to B12 deficiency. If a patient presents with both low B12 and elevated liver enzymes:
Investigate the liver enzyme elevation independently using the standard diagnostic approach 1:
- Assess for metabolic syndrome, obesity, diabetes (NAFLD risk factors)
- Screen for viral hepatitis, alcohol use
- Review medications for hepatotoxicity
- Consider imaging (ultrasound first-line for hepatocellular pattern)
Treat the B12 deficiency separately with oral crystalline cobalamin 1,000 µg/day (or parenteral if malabsorption/pernicious anemia) 2
Look for a common underlying cause that might explain both findings:
- Malabsorption syndromes (celiac disease, inflammatory bowel disease)
- Chronic liver disease causing both hepatocyte injury and impaired B12 metabolism
- Malnutrition or alcoholism affecting both nutritional status and liver function
Bottom Line
Elevated AST/ALT requires evaluation for true hepatocellular causes 1. The coexistence of low B12 is coincidental or reflects the liver disease itself affecting B12 metabolism, not B12 deficiency causing liver injury. Pursue standard workup for abnormal liver function tests while addressing B12 deficiency as a separate issue.